Clinical practice guidelines for IgG4-related sclerosing cholangitis

Terumi Kamisawa, Takahiro Nakazawa, Susumu Tazuma, Yoh Zen, Atsushi Tanaka, Hirotaka Ohara, Takashi Muraki, Kazuo Inui, Dai Inoue, Takayoshi Nishino, Itaru Naitoh, Takao Itoi, Kenji Notohara, Atsushi Kanno, Kensuke Kubota, Kenji Hirano, Hiroyuki Isayama, Kyoko Shimizu, Toshio Tsuyuguchi, Tooru ShimosegawaShigeyuki Kawa, Tsutomu Chiba, Kazuichi Okazaki, Hajime Takikawa, Wataru Kimura, Michiaki Unno, Masahiro Yoshida

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

IgG4-related sclerosing cholangitis (IgG4-SC) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4-related disease. Although clinical diagnostic criteria of IgG4-SC were established in 2012, differential diagnosis from primary sclerosing cholangitis and cholangiocarcinoma is sometimes difficult. Furthermore, no practical guidelines for IgG4-SC are available. Because the evidence level of most articles retrieved through searching the PubMed, Cochrane Library, and Igaku Chuo Zasshi databases was below C based on the systematic review evaluation system of clinical practice guidelines MINDS 2014, we developed consensus guidelines using the modified Delphi approach. Three committees (a guideline creating committee, an expert panelist committee for rating statements according to the modified Delphi method, and an evaluating committee) were organized. Eighteen clinical questions (CQs) with clinical statements were developed regarding diagnosis (14 CQs) and treatment (4 CQs). Recommendation levels for clinical statements were set using the modified Delphi approach. The guidelines explain methods for accurate diagnosis, and safe and appropriate treatment of IgG4-SC.

Original languageEnglish
Pages (from-to)9-42
Number of pages34
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume26
Issue number1
DOIs
Publication statusPublished - 2019 Jan

Keywords

  • Bile duct
  • Guideline
  • IgG4
  • Sclerosing cholangitis
  • Steroid

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Clinical practice guidelines for IgG4-related sclerosing cholangitis'. Together they form a unique fingerprint.

  • Cite this

    Kamisawa, T., Nakazawa, T., Tazuma, S., Zen, Y., Tanaka, A., Ohara, H., Muraki, T., Inui, K., Inoue, D., Nishino, T., Naitoh, I., Itoi, T., Notohara, K., Kanno, A., Kubota, K., Hirano, K., Isayama, H., Shimizu, K., Tsuyuguchi, T., ... Yoshida, M. (2019). Clinical practice guidelines for IgG4-related sclerosing cholangitis. Journal of Hepato-Biliary-Pancreatic Sciences, 26(1), 9-42. https://doi.org/10.1002/jhbp.596